Shay Capital’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,145,580
Closed -$2.49M 579
2022
Q2
$2.49M Sell
2,145,580
-354,503
-14% -$371K 0.5% 38
2022
Q1
$2.7M Sell
2,500,083
-1,625,957
-39% -$1.23M 0.35% 37
2021
Q4
$2.97M Buy
4,126,040
+3,866,040
+1,487% +$3.13M 0.49% 37
2021
Q3
$234K Buy
+260,000
New +$313K 0.03% 378

Shay Capital's MBII Position: Q3 2022 in Review

Shay Capital sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 2,145,580 shares — an estimated $2.49M sold.

Shay Capital first reported a position in MBII in Q3 2021 and held it in 4 quarters. The position peaked at $2.97M in Q4 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • Shay Capital reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • Shay Capital sold 2,145,580 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $2.49M.
  • Shay Capital first reported a position in Marrone Bio Innovations, Inc. in Q3 2021 and held it in 4 quarters.
  • Shay Capital's Marrone Bio Innovations, Inc. position peaked at $2.97M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Shay Capital's 13F filing for Q3 2022, filed 14 Nov 2022.